Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial.
Yan Wang, Xingsheng Hu, Guangyu An, Cuiying Zhang, Jin Wu, Diansheng Zhong, Yan Zhang, Wuyun Su, Min Zhao, Cuimin Ding, Aimin Zang, Gang Cheng, Da Jiang, Li Zhang, Xi Li, Shucai Zhang, Li Mao, Lieming Ding, Li Liang, Junli Liu, Xiaohui He, Yongqun Li, Huaqing Wang
Clinical cancer research : an official journal of the American Association for Cancer Research 2021;26(13):3162-3171